Skip to content

The Buckle BKE Increase Decrease In Receivables

Increase Decrease In Receivables at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$13.1M-1,256%
V2X logo
V2XVVX
$90.7M+1,495%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$474K-96.6%
Lithium Americas logo
Lithium AmericasLAC
$585K+760%
Schneider National logo
Schneider NationalSNDR
$59.9M+558%
Seaboard logo
SeaboardSEB
-$7M-600%

Other financials

Income statement

See full
Revenue$288.7M+6.1%
Gross profit$133.5M+5.1%
Operating income$59.5M+36.5%
Net income$46.9M+33.2%
EPS (diluted)$0.92+31.4%

Balance sheet

See full
Cash & equivalents$266.2M-1.0%
Total debt$410.9M+11.1%
Total equity$458.9M+3.1%
Total assets$1.0B+7.3%

Cash flow

See full
Operating cash flow$49.3M+59.2%
CapEx$14.7M+28.6%
Free cash flow$34.7M+77.1%

Valuation

See full
Market cap$2.3B+59.6%

Profitability

See full
Gross margin48.9%+0.1pp
Operating margin21.1%+1.3pp
Net margin16.8%+0.9pp
FCF margin16.8%+0.5pp

Returns & leverage

See full
Return on equity49%+4.4pp
Debt / equity0.9×+0.1×
Current ratio-0.1×

Where this comes from

Reported directly by The Buckle in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInReceivables.

The official record: The Buckle’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Buckle's increase decrease in receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Buckle's increase decrease in receivables?
The Buckle (BKE) reported increase decrease in receivables of -$3.7M in Q1 2026.
How has The Buckle's increase decrease in receivables changed year-over-year?
The Buckle's increase decrease in receivables decreased by 378.3% year-over-year, from $1.33M to -$3.7M.